Currently, many cases of mpox patients living with the human immunodeficiency virus (HIV)
have been reported. Immunocompromised mpox patients, including those living with HIV are …

Abstract Purpose of Review We reviewed the available literature on mpox in People with
HIV (PWH). We highlight special considerations of mpox infection related to epidemiology …

Human mpox is occurring worldwide, however, evidence from the Asian Pacific Region is
limited. In this multicenter cross‐sectional study, information of confirmed mpox cases …

Objectives: This study aimed to analyze characteristics of mpox hospitalization in a Brazilian
cohort, further exploring the impact of HIV on mpox-related outcomes and hospitalization …

Early UK surveillance data revealed that people living with HIV were overrepresented
among cases of monkeypox (mpox). However, it remains unknown whether mpox infection …

Background During the 2022 mpox outbreak most patients were managed as outpatients,
but some required hospitalization. Uncontrolled human immunodeficiency virus (HIV) has …

Abstract Purpose of Review The global outbreak of mpox has brought renewed attention to a
previously neglected disease which is particularly severe in people with underlying …

Summary Background By October 30, 2022, 76,871 cases of mpox were reported
worldwide, with 20,614 cases in Latin America. This study reports characteristics of a case …

Sub-Saharan Africa (SSA) is disproportionately affected by mpox and HIV. We described
epidemiologic trends and clinical experiences in the management of mpox in people living …

Background: Monkeypox (Mpox) is a reemerging, neglected viral disease. By May 2023,
worldwide Mpox cases surpassed 87,000. Predictive factors for hospitalization with Mpox …